Ann: Proteomics International seeks FDA approval for PromarkerD, page-163

so I googled US Kidney Disease and it tells me kidney disease affects 37 million people in the US.
hmm. At US$55 a test assuming testing to be done every 12 months?? Let's assume PD test 10% of these folk.
This equates to an income of US$203M per year on testing only 10% of the US population.
that's absurd!!!! Especially when you start thinking about all the European countries and China.....
companies are normally valued at multiples of their earnings.. I honestly can't see how PIQ will remain under a $1Bn market cap once they are dialed in.
Makes for an exciting future and certainly clarifies to me that the shares on offer are still very reasonably valued.
GLTAHs